Screening biomarkers for predicting the efficacy of immunotherapy in patients with PD-L1 overexpression

PURPOSE: Immunotherapy plays an important role in non-small cell lung cancer (NSCLC); in particular, immune checkpoint inhibitors (ICIs) therapy has good therapeutic effects in PD-L1-positive patients. This study aims to screen NSCLC patients with PD-L1-positive expression and select effective bioma...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xiaodan, Yu, Bo, Shen, Yanli, Zhao, Yan, Fu, Xiyujing, Zhu, Yunji, Gu, Guomin, Liu, Chunling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587271/
https://www.ncbi.nlm.nih.gov/pubmed/37468609
http://dx.doi.org/10.1007/s00432-023-05160-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587271/
https://www.ncbi.nlm.nih.gov/pubmed/37468609
http://dx.doi.org/10.1007/s00432-023-05160-9

Ejemplares similares